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Abstract
Insulin resistance plays a central role in type 2 diabetes and obesity, which develop as a consequence of genetic and
environmental factors. Dietary changes including high fat diet (HFD) feeding promotes insulin resistance in rodent models
which present useful systems for studying interactions between genetic background and environmental influences
contributing to disease susceptibility and progression. We applied a combination of classical physiological, biochemical and
hormonal studies and plasma 1H NMR spectroscopy-based metabonomics to characterize the phenotypic and metabotypic
consequences of HFD (40%) feeding in inbred mouse strains (C57BL/6, 129S6, BALB/c, DBA/2, C3H) frequently used in
genetic studies. We showed the wide range of phenotypic and metabonomic adaptations to HFD across the five strains and
the increased nutrigenomic predisposition of 129S6 and C57BL/6 to insulin resistance and obesity relative to the other
strains. In contrast mice of the BALB/c and DBA/2 strains showed relative resistance to HFD-induced glucose intolerance and
obesity. Hierarchical metabonomic clustering derived from 1H NMR spectral data of the strains provided a
phylometabonomic classification of strain-specific metabolic features and differential responses to HFD which closely
match SNP-based phylogenetic relationships between strains. Our results support the concept of genomic clustering of
functionally related genes and provide important information for defining biological markers predicting spontaneous
susceptibility to insulin resistance and pathological adaptations to fat feeding.
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Introduction
Reduction in the sensitivity to the peripheral and central actions
of insulin (insulin resistance) is associated with several of the most
frequent and prevalent human disorders, including type 2 diabetes
mellitus, obesity and dyslipidemia [1,2]. The etiology of these
diseases is complex and involves genetic risk factors and
environmental influences including sedentary lifestyle and dietary
fat intake [3,4,5]. Numerous mechanisms contribute to insulin
sensitivity regulation in several tissues (skeletal muscles, fat, liver)
[6], thus making difficult pathophysiological investigations into the
manifestation of insulin resistance in humans.
Rodent models of spontaneous or experimentally-induced
insulin resistance are powerful tools for characterizing the
physiological and molecular mechanisms involved in the onset
and progression of diabetes and obesity. Targeted mutagenesis is
extensively used to investigate the consequences of the inactivation
of known genes on the regulation of insulin sensitivity in vivo [7].
High fat diet (HFD) feeding is also widely used in rodents to study
the impact of dietary changes on the onset and progression of
insulin resistance and obesity [8]. Strain-specific metabolic and
hormonal adaptations to gene inactivation [9] or fat feeding
[10,11,12,13] in mice suggest that naturally-occurring genetic
polymorphisms modulate spontaneous and experimentally-in-
duced pathophysiological patterns. These models are therefore
more relevant to polygenic obesity in human than models of gene
inactivation.
Novel experimental systems and concepts have emerged to
facilitate detection of linkages between genetic variants and disease
phenotypes [14,15,16,17]. Applying these strategies requires
extensive knowledge of spontaneous and experimentally-induced
phenotypic features in inbred founder strains [18], which can be
maximized with consistent experimental designs aimed at
standardizing general maintenance conditions, diet composition
and duration of HFD feeding, assays and high density phenotype
acquisition tools and technologies [19].
Metabonomics in particular is designed to identify in biological
samples qualitative and quantitative changes in metabolic profiles
[20] that underlie disease process and drug response in humans
and model organisms [21]. Its role is central to the emerging field
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of nutrigenomics [22], which explores the genome-wide effects of
nutrition, for isolating biomarkers characterizing dietary changes
that can predict disease initiation and progression in different
genetic makeups.
We have characterized the short-term consequences of fat
feeding in five inbred strains (C57BL/6, 129S6, BALB/c, DBA/2,
C3H) commonly used in genetic studies and as recipients for gene
inactivation experiments (C57BL/6, 129S6) using an approach
combining 1H NMR spectroscopy-based metabonomics and
classical physiological and biochemical methods. Results from
standardized multimodal phenotyping provide information on
genetic backgrounds predisposing to spontaneous diabetes, and
strain-specific patterns of metabolic and hormonal adaptations to
fat feeding underlying mechanisms involved in the onset and
progression of insulin resistance, diabetes and obesity.
Materials and Methods
Animals
Male mice of five inbred strains, C57BL/6JOxjr, BALB/cOxjr,
DBA/2OlaHsd, 129S6/SvEvOxjr and C3H/He NHsd were used.
These strains are referred as C57BL/6, BALB/c, DBA/2, 129S6
and C3H throughout the text. Colonies of C57BL/6, BALB/c and
129S6 were bred locally using stocks from the Jackson laboratory.
DBA/2 and C3H mice were obtained from a commercial supplier
(Harlan, UK). All mice were kept under standard maintenance
conditions on 12h light/dark cycle. All experiments were carried
out in accordance with national guidelines.
Mice were weaned at 21 days and caged in groups of 10. They
were fed a normal carbohydrate (CHD) diet containing 5% fat,
19% protein and 3.5% fibre (S&K Universal Ltd, Hull, UK). At
five weeks, mice were transferred on 40% high fat diet (HFD)
containing 32% lard oil and 8% corn oil (Special Diet Services,
Witham, UK) ad libitum. Strain- and age-matched groups
remained on CHD throughout the experiment.
Glucose tolerance and insulin secretion tests
Simplified intraperitoneal glucose tolerance tests (IPGTT) were
performed in overnight fasted mice at 8 weeks of age (i.e. after
3 weeks of HFD feeding for the experimental group) as previously
described [23]. Briefly, mice were anesthetized with an intraperito-
neal injection of sodium pentobarbital (Sagatal, Rhoˆne Me´rieux,
Harlow, UK) and a solution of glucose (2g/kg body weight) was
injected intraperitoneally. Blood samples were collected from the tip
of the tail vein before the injection and 15, 30 and 75 minutes
afterward. Plasma samples were stored at -80uC until assayed for
immunoreactive insulin (IRI). Cumulative glycemia (CumG) and
insulinemia (CumIRI) were calculated as the increment of the values
of plasma glucose and insulin, respectively, during the test. The ratio
CumIRI/CumG was used as an index of insulin secretion.
Incremental plasma insulin and glucose values above baseline,
integrated over 75 min after glucose injection were used to calculate
indices of insulin secretion (DIRI) and glucose tolerance (DG). The K
parameter was calculated as the slope between glucose or insulin
values at time points 15 and 75 minutes.
Tissue sampling
Mice were allowed to recover for 4 days after the IPGTT. Body
weight (BW) and length (BL) (distance from the tip of the nose to the
base of the tail) were determined and BMI was calculated as BW/
BL2. Mice were individually housed in metabolic cages for one
overnight to determine food consumption. Digestible energy was
calculated by multiplying the amounts of CHD and HFD eaten by
14 and 22.17, respectively. Following an overnight fast, mice were
then killed by CO2 asphyxiation and a blood sample was collected
on heparin by cardiac puncture. Blood was centrifuged and plasma
was removed and stored at 280uC until lipid assay and 1H NMR
metabonomic profiling. Retroperitoneal and epididymal fat pads
(RFP and EPD, respectively) were collected and weighed. Adiposity
indices (AI) were calculated as the ratio between RFP or EPD weight
to BW (AI_RFP and AI_EPD, respectively).
Analytical methods
Blood glucose concentration was determined during the IPGTT
with a glucose meter (Accucheck, Roche Diagnostics, Welwyn
Garden City, UK). Plasma IRI was determined on a 10 ml aliquot
with an ELISA kit (Mercodia, Uppsala, Sweden). Plasma
concentrations of total cholesterol (TC), high density lipoprotein
cholesterol (HDL), low density lipoprotein cholesterol (LDL) and
triacylglycerol (TG) were determined using diagnostic enzymatic/
colorimetric kits (ABX, Shefford, UK) on a Cobas Mira Plus
automatic analyser (ABX, Shefford, UK).
Metabolic profiling in plasma samples
1H NMR spectra were acquired at 600.22 MHz on a Bruker
Avance-600 spectrometer (Bruker, Coventry, UK) using 100 ml of
plasma diluted in 400 ml of a 9g/l saline solution (20% 2H2O/H2O
v/v). Standard monodimensional spectra were acquired using a
selective presaturation pulse sequence for water signal suppression as
described elsewhere [24]. For each acquisition, 128 transient free
induction decays (FID) were collected into 32,768 data points using a
spectral width of 20 ppm. The FIDs were convoluted with an
exponential weighting function corresponding to a line broadening
of 0.3 Hz before Fourier transform. The NMR spectra were
corrected for phase and baseline distortions using in-house software
and referenced to the glucose a-anomeric signal (d5.23) [24]. The 1H
NMR spectra were imported as full-spectral resolution data [25].
Each variable reflects the exact NMR datapoint to which it was
associated. To remove the effects of variation in the suppression of
the water resonance, the region (d4.5–5.0) was discarded. The data
were normalized by using a noise variance normalisation. The final
dataset was then mean-centred prior to analysis [25].
Statistical methods
Phenotypic data collected from the animals were analyzed using
the SPSS version 12.0 statistical package. The univariate General
Linear Model (GLM), which allows the selection of covariates to
account for variance that is not due to the dependent variable, was
used to analyse phenotypes. Fisher’s LSD and Tamhane’s T2 post
hoc tests were used according to Levene’s test for equality of variance
in order to assess differences between the strains on carbohydrate
diet and high fat diet. Bivariate Pearson pairwise correlations were
obtained using R package ‘rma’ and plotted in the form of a
correlation matrix using the following phenotypes: glycemia,
insulinemia, homeostasis model assessment of insulin resistance
(HOMA), plasma lipids, body weight, BMI, AI_RFP and AI_EPD.
Principal component analysis (PCA) was used to visualize the data
and for quality control again using the phenotypes mentioned in
obtaining the Bivariate Pearson pairwise correlations.
Multivariate pattern recognition of 1H NMR spectra
The O-PLS algorithm derives from the basic partial least
squares (PLS) regression (15). In discriminant analysis version, it
explains maximum separation between class samples y (1 dummy
variable for a two-class discrimination in our case) using the NMR
data X, by decomposing the covariation matrix (yTX) into 1
predictive O-PLS component and several orthogonal signal
Biology of High Fat Feeding
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correction (OSC) components [26]. Further details on O-PLS
standard implementation in metabonomics are given in ref [25].
The model coefficients locate the NMR variables associated to a
specific class in y. The model coefficients were then back-scaled in
order to enhance interpretability of the model: in the coefficient
plot, the intensity corresponds to the mean-centred model
(variance) the colour-scale derives from the unit variance-scaled
model (correlation).
Hierarchical clustering trees (HCTs)
Hierarchical clustering was used to generate phylogenetic and
phylometabonomic trees based on SNP and NMR data, respective-
ly. HCTs are measures similarity or dissimilarity between observa-
tions computed from the data matrix. Dissimilarity coefficients are
symmetric, i.e. d(A,B)=d(B,A) and non-negative i.e. d(A,A)=0
and can be displayed as dendrograms. The single-linkage method
applied here uses the maximum Euclidean distance between two
profiles (SNP genotypes or 1H NMR metabotypes) as the
dissimilarity measure. SNP data were coded as Strain Distribution
Patterns (SDP) prior to building the phylogenetic trees. Average 1H
NMR spectra for each strain and diet condition were used to build
phylometabonomic classifications.
Results
Global impact of genetic differences on metabolic and
hormonal regulations
We used PCA of classical metabolic and hormonal variables in
HFD- and CHD-fed mice to underline strain and diet latent factors
underlying global phenotypic variations (Fig 1). Principal component
(PC) 1 highlighted differences between two main groups on CHD
(C3H, DBA2, 129S6 and C57BL/6, BALB/c). Whist PC1 also
allowed the separation of HFD-fed and CHD-fed mice of the 129S6
strain, PC2 predominantly accounted for fat feeding effects in DBA/
2 and C57BL/6 mice. Glycemia and adiposity indices were the top
ranking phenotypes responsible for the separation between HFD-fed
and CHD-fed 129S6 mice, whereas insulin data contributed to the
separation of fat fed and CHD-fed groups identified by PC2 (Figure
S1). In both BALB/c and C3H, PCA resulted in clustering the HFD-
and CHD-fed groups, suggesting that fat feeding had little impact on
the phenotypes analyzed (Fig 1). Individual phenotypes were
analysed further to refine these apparent strain-specific patterns of
adaptation to HFD feeding.
Body growth, adiposity and lipid metabolism
When fed CHD, mice of the strains C3H and C57BL/6 were
significantly heavier than DBA/2 and BALB/c mice (p,0.001)
(Table 1). C3H mice consumed significantly more CHD than the
other four strains. Adiposity indices were significantly greater in
DBA/2 mice than in the other mouse strains (p,0.001). After
three weeks of HFD feeding, BW, BMI and adiposity indices were
consistently significantly increased in 129S6 and C3H strains when
compared to age-matched CHD-fed controls. These variables
were unaffected by HFD in DBA/2 mice. The other two strains
showed an intermediate pattern of adaptation to fat feeding
characterized by increased BW and BMI without changes in
adiposity indices in C57BL/6 or unchanged BW and BMI, despite
significantly increased adiposity indices (+.130%) in BALB/c.
The latter strain was the only model to exhibit increased food
energy consumption on HFD (+14%). HFD induced a significant
Figure 1. Principal component analysis (PCA) in inbred mice fed control (CHD) or high fat diet (HFD). PCA was carried out with classical
physiological data (glucose tolerance, insulin secretion, BW, BMI and adiposity indices) collected in eight week old mice fat fed for three weeks and
controls. Prior to PCA, phenotypic variables were mean centered and reduced to a variance of 1. Phenotypes contributing to separation between
models are described in Figure S1.
doi:10.1371/journal.pone.0001668.g001
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reduction of food energy consumption in C57BL/6 (245%), C3H
(235%) and DBA/2 (225%) mice.
Plasma levels of total cholesterol (TC) and LDL-C were similar in
the 5 strains on CHD, whereas HDL-C was significantly lower in
C57BL/6 than 129S6 and DBA/2 mice and plasma TG levels were
significantly more elevated inDBA/2 and C57BL/6 than 129S6 and
BALB/c mice (Fig. 2). Fat feeding in 129S6 mice induced a
statistically significant general raise of plasma TC, HDL-C, LDL-C
and TG. Some of these effects (TC, HDL-C) were specific to this
strain. The effect of HFD on increased plasma LDL-C was also
observed in DBA/2 mice. Plasma TG levels were increased by HFD
in BALB/c and paradoxically reduced by HFD in C57BL/6.
Overall these individual phenotype features in the mouse
models are consistent with the proposed complex pattern of
adaptations to fat feeding derived by PCA.
Glucose homeostasis and insulin secretion
Results from glucose tolerance and in vivo insulin secretion
testing were used to identify strain differences and similarities in
the regulation of these processes when mice are fed CHD or HFD.
On CHD, C57BL/6 mice had significantly higher fasting glycemia
(P,0.001) than the other strains (6.260.1 mM in C57BL/6 when
compared to 4.460.1 mM in 129S6, 5.660.1mM in BALB/c,
5.460.1 mM in DBA/2 and 5.860.2 mM in C3H) (Fig. 3A).
Fasting insulinemia was similar in the 5 strains (Fig. 3B). All CHD
fed strains showed similar glycemic patterns during the IPGTT
(Fig. 3A), but higher cumulative glycemia (CumG) during the
IPGTT in C57BL/6 mice than in the other strains (P,0.01)
suggested relative glucose intolerance in this strain (Fig. 4A). Mice
of the C57BL/6 and DBA/2 strains showed greater glucose
induced insulin secretion capacity than the other strains (Fig. 3B),
as evidenced by the higher values of cumulative insulin (CumIRI)
in the former strains (Fig. 4B).
When fed HFD, all strains became significantly hyperglycemic
(Fig. 3A). Glucose intolerance assessed by CumG values developed
only in C57BL/6 and 129S6 mice (Fig. 4A) and appeared more
marked in 129S6 mice (Fig.3A). Fasting hyperinsulinemia
developed in all strains but C3H (Fig. 3B). Mice of the 129S6,
BALB/c and DBA/2 strains showed significantly enhanced
glucose induced insulin secretion in vivo (Fig. 4B).
Overall, even though the strains exhibited specific patterns of
regulations of glucose homeostasis and insulin secretion, three
weeks of HFD feeding generally induced profound hyperglycemia
and hyperinsulinemia. Strongly significant enhancement of fasting
insulinemia and insulin secretion induced by HFD in 129S6,
BALB/c and DBA/2 had little effect on glucose tolerance (BALB/
c, DBA/2) or was associated with glucose intolerance (129S6),
suggesting insulin resistance in these strains.
Phenotype correlations
To investigate relationships between phenotypes, individual
correlations were calculated. When phenotype data from all strains
were analyzed, the highest correlations in both fat fed and CHD
fed groups were, as expected, for intra-experimental measure-
ments, i.e. between glucose tolerance data and between insulin
secretion data and between adiposity indices and plasma TG levels
(Fig. 5). Significant correlations between plasma lipids and insulin
secretion data, body weight, BMI and adiposity indices were
observed only in the fat fed group. Correlations between fasting
insulinemia and insulin secretion data were also only detected
specifically in the fat fed group.
This pattern of phenotype relationships was generally conserved
when individual strains were tested (Figure S2). Strain-specific
phenotype relationships included significant correlations between
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glucose tolerance and insulin secretion (CHD-fed BALB/c), body
weight (CHD-fed DBA2 and C3H) or adiposity indices (CHD-fed
C3H). Significant strain-specific correlations were also observed
for fasting insulinemia and adiposity indices (CHD-fed C57BL/6)
or plasma TG (CHD-fed 129S6). In HFD-fed mice, lack of
relationship between fasting insulin and insulin secretion was
specific to DBA/2 and C3H.
Plasma 1H NMR metabonomic profiling
To identify strain-specific metabolic changes in models predis-
posed or resistant to spontaneous or diet-induced relative glucose
intolerance, adiposity or hyperlipidemia, 1H NMR spectral data
from CHD- and HFD-fed mice were independently analyzed using
O-PLS-DA (Fig 6 and Figure S3). Goodness of fit statistics
corresponding to each model is given in Table 2. In the CHD-fed
group the most significant metabolic alterations that contributed to
strain separation included increased levels of glucose in C57BL/6,
citrate and pyruvate in 129S6, and lactate, lipids and phosphocho-
line (PC) in C3H (Figure S3). Reduced concentrations of lipids,
choline and phosphocholine (PC) were specific to C57BL/6, and
decreased levels of glucose, lactate and oxoglutarate to DBA/2. Even
though several strain-specific metabolic changes were conserved in
HFD-fed mice (e.g. lipids, choline, PC in C57BL/6 and oxoglutarate
in DBA/2), adaptations to HFD also involved altered levels of
Figure 2. Effects of high fat diet (HFD) on plasma lipids in inbred mouse strains. The effects of fat feeding on total cholesterol (T-C) (A),
HDL-C (B), LDL-C (C) and triacylglycerol (D) are shown. Values are expressed as means6SEM. Data were obtained from over 8 mice of each group.
Differences between groups were assessed by Fisher’s LSD and Tamhane’s T2 post hoc tests. *p,0.05, **p,0.01, ***p,0.001, significantly different
to CHD fed mice of the same strain.
doi:10.1371/journal.pone.0001668.g002
Figure 3. Glucose tolerance (A) and glucose induced insulin secretion in vivo (B) in inbred mouse strains. Data are derived from 8 week
old mice fed CHD or HFD for three weeks. Data shown are mean6SEM (n= 9 to 86 mice per group). Differences between groups were assessed by
Fisher’s LSD and Tamhane’s T2 post hoc tests. *p,0.05, **p,0.01, ***p,0.001, significantly different to CHD fed mice of the same strain.
doi:10.1371/journal.pone.0001668.g003
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different sets of metabolites specific to C57BL/6 (lactate), 129S6
(PUFAs, PC), BALB/c (b-hydroxybutyrate), DBA/2 (alanine,
pyruvate), and C3H (phenylacetate, creatine).
Combined analysis of genetic and dietary factors showed that
group separation was characterized by differential regulation of
the concentrations of lactate (C3H, DBA/2), glucose (BALB/c,
DBA/2) and PC (C3H, 129S6) (Fig. 6). Increased PC level
remained significantly associated with 129S6. BALB/c and 129S6
mice shared conserved metabolic patterns, including increased
concentration of lipids and b-hydroxybutyrate.
To test the existence of a relationship between genetic
variability and strain-specific metabolic patterns, we used datasets
of over 10,000 SNP recently produced in these five strains [27]
(http://gscan.well.ox.ac.uk/gs/strains.cgi) to derive phylogenetic
clustering, which we compared to 1H NMR-based metabotypic
clusters (Fig. 7). Resulting phylometabonomic patterns reflect
natural and diet-induced metabolic variability between strains.
These patterns were clearly different in CHD- and HFD-fed
groups (Fig. 7) and when both strain and dietary conditions were
used for clustering analysis (Fig. 6). Metabolic patterns in HFD-fed
mice closely match phylogenetic relationships between the strains
tested. The apparent metabolic refocusing in HFD-fed animals
underlines the importance of diet-reactive genetic polymorphisms
in these animals, i.e. nutrigenomic predisposition.
Discussion
We have used a consistent series of protocols and standardized
methods and experimental conditions to comprehensively assess
the short-term metabolic and hormonal consequences of fat
feeding in five genetically well-characterized inbred mouse strains.
PCA identified the strongest spontaneous and diet-induced strain
differences and similarities, which were refined by physiological
and biochemical studies. Our findings highlight the impact of
genetic differences on the regulation of insulin secretion and
action, and the complex pathophysiological patterns of adapta-
tions to HFD feeding, which underlie nutrigenomic predispositions
to insulin resistance and obesity.
The robustness of our dataset lies in the application of strictly
standardized and synchronized phenotyping which minimized
environmentally-induced phenotype variations and allowed reli-
able comparisons between strains and conditions for multiple
phenotypes. Results from physiological tests generally confirm
published evidence of poor glucose homeostasis that C57BL/6
mice spontaneously exhibit [11,12,23] and high insulin secretion
capacity in C57BL/6 and DBA/2 strains relative to BALB/c and
C3H [23]. Comparisons with other mouse phenotype datasets,
often aimed at identifying contrasting biological variables in a pair
of strains used in a genetic cross, remain difficult due to differences
in genetic backgrounds, technical assays and maintenance
conditions that inevitably induce phenotype variations, even in
self contained experiments [28]. Of relevance to our study, the
mutation in the nicotinamide nucleotide transhydrogenase gene
which causes insulin deficiency in C57BL/6 mice [29] was not
found in our C57BL/6 colony (data not shown).
Figure 4. Effects of high fat diet (HFD) on cumulative glycemia
(A) and insulinemia (B) in mice. Values of cumulative glycemia
(CumG) and insulinemia (CumIRI) are expressed as means6SEM. Data
are derived from 15 to 40 mice per group. Differences between groups
were assessed by Fisher’s LSD and Tamhane’s T2 post hoc tests.
***p,0.001, significantly different to CHD fed mice of the same strain.
doi:10.1371/journal.pone.0001668.g004
Figure 5. Correlation matrices plotted for all strains on HFD
and CHD diets. Negative and positive correlations are shown for each
pair of phenotypes in green and red, respectively. Bivariate Pearson
pairwise correlations were derived from the R package ‘rma’. Asterisks
indicate statistically significant correlations. Correlation plots for
individual strains are shown in Figure S2. 1, IPGTT glycemia time 0; 2,
IPGTT glycemia time 15; 3, IPGTT glycemia time 30; 4, IPGTT glycemia
time 75; 5, IPGTT Cumulative glycemia (CumG); 6, IPGTT glucose
tolerance index (DG); 7, K glucose parameter; 8, Homa index; 9, IPGTT
insulinemia time 0; 10, IPGTT insulinemia time 15; 11, IPGTT insulinemia
time 30; 12, IPGTT insulinemia time 75; 13, IPGTT Cumulative
insulinemia (CumIRI); 14, IPGTT insulin secretion index (DIRI); 15, K
insulin parameter; 16, IPGTT insulin secretion index (CumIRI/CumG); 17,
IPGTT insulin secretion index (DIRI/DG); 18, plasma total cholesterol; 19,
plasma high density lipoprotein cholesterol; 20, plasma low density
lipoprotein cholesterol; 21, plasma triacylglycerol; 22, body weight; 23,
body mass index; 24, adiposity index (retroperitoneal fat); 25, adiposity
index (epididymal fat).
doi:10.1371/journal.pone.0001668.g005
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Fat feeding introduced an additional level of complexity in
strain-specific metabolic and hormonal patterns. Consensus
features of adaptation to HFD in all strains tested were
hyperglycemia and hyperinsulinemia. Fat fed mice exhibited some
evidence of insulin resistance as increased insulin secretion was
associated with glucose tolerance which was either deteriorated
(C57BL/6, 129S6) or unchanged (BALB/c, DBA/2, C3H), and
adiposity indices either increased (129S6 BALB/c, C3H) or were
unchanged (C57BL/6, DBA/2). Only C57BL/6 and 129S6
strains developed marked glucose intolerance and the latter
exhibited the most severe phenotypic alterations characterized
by increased body weight, adiposity indices and plasma lipid levels.
Although our results largely agree with data from other studies in
HFD-fed mice [13,30] we noted inconsistencies that may be caused
by above outlined factors and differences in HFD composition and
fat feeding duration. Results from our laboratory showed that
phenotype alterations in 129S6 fed the same 40% HFD were more
profound when fat feeding was prolonged (15 weeks) and combined
obesity, hyperlipidemia, enhanced insulin secretion, glucose intoler-
ance and fatty liver [31,32]. In contrast HFD-fed BALB/c mice
maintained in identical conditions showed both enhanced insulin
secretion and markedly improved glucose tolerance, suggesting
normal or enhanced insulin sensitivity which may prevent fatty liver
in this strain [31]. In addition, increased severity of fatty liver and
obesity phenotypes in 129S6 mice fed a 40% HFD deficient in
choline illustrates the strong impact of apparently minor alterations
in diet composition on disease progression [31].
Correlative relationships between multiple phenotypes in fat fed
and control mice underlined strain-specific and conserved features
of susceptibility or resistance to diet induced obesity. Reduced
insulin secretion capacity in CHD-fed 129S6, BALB/c and C3H
mice relative to C57BL/6 and DBA/2 did not correlate with
HFD-promoted glucose intolerance which develops more prom-
inently in C57BL/6 and 129S6 mice. Interstrain differences in
insulin secretion in both fat fed and control mice did not correlate
with patterns of adiposity indices either. The integration of
metabonomic profiling data from fat fed and control mice in these
highly heterogeneous pathophysiological patterns of response to
standardized HFD feeding potentially provides tools for identify-
ing predictive biomarkers associated with specific disease traits
determined by different genetic backgrounds. For example, altered
metabolism of choline and lipids appear to be central features of
129S6 which exhibits the strongest susceptibility to diet induced
obesity, diabetes and fatty liver as previously shown [31]. In the
context of nutrigenomics [22], metabolic profiles are particularly
important as they accurately document metabolic endpoints of
gene expression regulation at the organism level, which in contrast
to transcriptomics do not require prior knowledge of organ-specific
altered mechanisms [33].
Results from our study show that metabolites derived from
metabonomic profiles are associated with several types of strain-
Figure 6. 1H NMR metabonomics derived metabotypes supporting classification of 5 inbred mouse strains. O-PLS-DA model
coefficients were used for differential analysis between diets and strains in C3H (a), Dba2 (b), BALB/c (c), 129S6 (d) and C57Bl/6 (e). Global clustering
analysis (f) uses a scale which corresponds to the Euclidean distance between strains and depends on the dynamic range of the variables.
doi:10.1371/journal.pone.0001668.g006
Table 2. O-PLS-DA model goodness of fit statistics.
Model/Goodness of fit R2X R2Yhat Q2Yhat
C3H (CHD vs. HFD) 0.85 0.89 0.77
Dba2 (CHD vs. HFD) 0.76 0.95 0.90
BALB/c (CHD vs. HFD) 0.65 0.95 0.78
129S6 (CHD vs. HFD) 0.87 0.96 0.90
C57 (CHD vs. HFD) 0.85 0.87 0.71
CHD (5 strains) 0.96 0.91 0.78
HFD (5 strains) 0.98 0.94 0.84
For each O-PLS-DA model represented in Fig 6 and Fig SI 3, R2X, R2Yhat and
Q2Yhat are calculated according to Cloarec et al. [25].
doi:10.1371/journal.pone.0001668.t002
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specific disease signatures associated with HFD response, includ-
ing ketosis in BALB/c and lactic acidosis in C3H and DBA/2.
Evidence of dyslipidemia patterns, including increased PC level
remained significantly associated with 129S6, as previously
described in a gut microflora modulation context [31]. Mice of
the BALB/c and 129S6 strains shared conserved metabolic
patterns, including increased concentration of PUFA lipids and
increased ketosis (b-hydroxybutyrate and acetoacetate).
Testing causal relationships between metabotypes, pathophys-
iological traits and genetic polymorphisms in mice require similar
investigations in classical genetic crosses or in hybrids of the
heterogeneous stock [16] and the collaborative cross [15] which
both derive from strains tested in this study. We have recently
shown that untargeted 1H NMR metabonomic quantitative traits
can be mapped to the genome in an F2 cross, and that a
proportion of these co-localise with loci linked to pathophysiolog-
ical traits [34]. The definition of metabonomic clusters of 1H
NMR spectral data from strains of mice fed CHD and HFD,
which reflect the role of metabolic and genetic variations in strain
separation, indicates that metabonomic QTL mapping is possible
in mice and requires strictly standardized experimental conditions
in cohorts of hybrid mice. SNP-based phylogenetic relationships
between strains were generally consistent with established mouse
genealogy data [35,36,37] and closely match phylometabonomic
patterns in fat fed mice. These data highlight the important role of
genetic variants on metabolic regulations and support the
involvement of metabolic refocusing in HFD-fed mice. This
apparent concordance between phylogenetic trees, which estimate
haplotype conservation and divergence between strains, and diet-
specific phylometabonomic relationships supports the concept of
genomic clustering of functionally related genes [38].
Diet-induced changes in phylometabonomic patterns show that
murine plasma metabolome is strongly influenced by environ-
mental factors, resulting in a context-dependent modulation of the
genome-encoded traits. Such metabotypic variation may also
involve non-genomic influences including cooperative interactions
between microbial and mammalian metabolism, which have
emerged from metabonomic-based studies in humans and animal
models [39]. We have demonstrated in fat fed mice that
transgenomic effects result in strain-specific changes in the
abundance of metabolites processed by the gut microflora (e.g.
choline as discussed above), which contribute to fatty liver
predisposition and severity, and are therefore directly relevant to
disease susceptibility [31].
Summary
We report here the breadth of metabolic and hormonal patterns
of the spontaneous and nutrigenomic susceptibility to insulin
resistance, obesity and diabetes in inbred mouse strains. Results
from extensive phenotyping in different strains demonstrated the
varied pathophysiological consequences of fat feeding on interme-
diate phenotypes, rather than the development of a single phenotype
entity unifying glucose intolerance, hyperinsulinemia, obesity and
hyperlipidemia. Metabonomic biomarkers of adaptation to fat
feeding represent molecular targets for further studies designed to
test their power to predict susceptibility or resistance to spontane-
ously occurring and experimentally induced disease patterns.
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